Pfizer has already made its biggest deals, Bourla saysnews2026-08-04T17:24:27+00:00August 4th, 2026|Endpoints News|
Novo vs. Lilly: Q2’s cardiometabolic grudge matchnews2026-08-04T15:00:54+00:00August 4th, 2026|Endpoints News|
Otsuka succeeds with kidney drug; BioNTech downgrades revenue projectionnews2026-08-04T14:50:59+00:00August 4th, 2026|Endpoints News|
Akido is expanding AI for patient intake and diagnoses across 100 clinicsnews2026-08-04T12:11:16+00:00August 4th, 2026|Endpoints News|
Bayer eyes German launch of stroke drug despite spending cuts in the countrynews2026-08-04T11:00:57+00:00August 4th, 2026|Endpoints News|
Merck’s anti-TL1A antibody scores a win in hidradenitis suppurativa, fails in SSc-ILDnews2026-08-04T10:30:21+00:00August 4th, 2026|Endpoints News|
Post-Hoc Live: Who wants an AstraZeneca-Bristol Myers megadeal?news2026-08-04T10:00:19+00:00August 4th, 2026|Endpoints News|
Pathos does deals with AstraZeneca, China’s Alphamab, seeks up to $300M Series Enews2026-08-04T00:00:51+00:00August 4th, 2026|Endpoints News|